ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,661,000 | +349.5% | 28,534 | +193.1% | 0.00% | – |
Q3 2021 | $592,000 | +110.7% | 9,736 | +145.7% | 0.00% | – |
Q2 2021 | $281,000 | -52.1% | 3,963 | -55.1% | 0.00% | – |
Q1 2021 | $587,000 | -40.0% | 8,828 | -32.9% | 0.00% | -100.0% |
Q4 2020 | $978,000 | +140.9% | 13,160 | +150.2% | 0.00% | – |
Q3 2020 | $406,000 | -7.7% | 5,260 | -21.3% | 0.00% | – |
Q2 2020 | $440,000 | +430.1% | 6,686 | +256.0% | 0.00% | – |
Q1 2020 | $83,000 | -88.1% | 1,878 | -87.7% | 0.00% | -100.0% |
Q4 2019 | $696,000 | -55.3% | 15,329 | -54.9% | 0.00% | 0.0% |
Q3 2019 | $1,556,000 | +535.1% | 33,990 | +712.4% | 0.00% | – |
Q2 2019 | $245,000 | +807.4% | 4,184 | +495.2% | 0.00% | – |
Q4 2018 | $27,000 | +68.8% | 703 | +105.0% | 0.00% | – |
Q3 2018 | $16,000 | +6.7% | 343 | -2.8% | 0.00% | – |
Q2 2018 | $15,000 | +114.3% | 353 | +76.5% | 0.00% | – |
Q4 2017 | $7,000 | -97.7% | 200 | -98.3% | 0.00% | – |
Q3 2017 | $306,000 | +30500.0% | 12,000 | +18361.5% | 0.00% | – |
Q2 2017 | $1,000 | – | 65 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |